The Latest Cardiac and Vascular News
CareDx Testing Services Have Been Used in Over 30,000 Heart Transplant Patients and Over 90 Percent of Centers in the United States SOUTH SAN FRANCISCO, Calif., April 14, 2022 (GLOBE NEWSWIRE) — CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, […]
Centers for Medicare & Medicaid Services (CMS) issues new Healthcare Common Procedure Coding System (HCPCS) codes for Dayspring lower extremity active compression OAKLAND, Calif.–(BUSINESS WIRE)–Koya Medical, a healthcare company on a mission to transform lymphatic and venous care through a comprehensive suite of innovative, people-centric platforms, today announced the U.S. […]
Studies have linked hypertension and obesity to various heart issues TAMPA, Fla., April 13, 2022 /PRNewswire/ — Smart Meter, a leader in remote patient monitoring (RPM) solutions, helps RPM providers deliver disease and condition-specific products and services to healthcare providers. Cardiovascular Disease (CVD) was responsible for more than 19 million deaths worldwide in […]
WASHINGTON, April 13, 2022 /PRNewswire/ — Anekwe E. Onwuanyi, MD, FACC, was installed as the 19th President of the Association of Black Cardiologists (ABC) during the Spring 2022 Membership Meeting. He is the first board-certified, advanced heart failure specialist to hold the position in ABC’s nearly 50-year history. Dr. Onwuanyi is Professor of Medicine […]
WALTHAM, Mass., April 12, 2022 /PRNewswire/ — Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative first-in-class medicines that meet significant unmet medical needs, today announced that on April 5, 2022, the compensation committee of the company’s board of directors granted five new non-executive employees options […]
DEDUCE study demonstrates AUC of 0.86 in overall cohort, including more than 700 prospective samples AUSTIN, Texas, April 13, 2022 /PRNewswire/ — Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced that its clinical validation study1 on its donor-derived cell-free DNA (dd-cfDNA) test for the assessment of acute rejection in heart transplant patients, […]
Analysis of pooled Phase 3 data demonstrated 26.5% reduction vs. placebo in LDL-C from bempedoic acid monotherapy and 39.2% reduction vs. placebo in LDL-C from bempedoic acid and ezetimibe fixed-dose combination in patients not taking statins ANN ARBOR, Mich., April 13, 2022 (GLOBE NEWSWIRE) — Esperion (NASDAQ: ESPR) today announced […]
VANCOUVER, April 13, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) is pleased to announce the results of the votes on matters considered at its Annual General and Special Meeting of Shareholders held on April 12, 2022 in Vancouver, B.C. (the “Meeting”). At the Meeting, the […]
MORRISVILLE, N.C., April 12, 2022 (GLOBE NEWSWIRE) — Liquidia Corporation (NASDAQ: LQDA) (“Liquidia”) announced today that it has commenced an underwritten public offering of its common stock. All of the shares in the proposed offering will be sold by Liquidia. In addition, Liquidia expects to grant the underwriters a 30-day […]
77K square-foot facility to accommodate growth NEWTON, Mass.–(BUSINESS WIRE)–Corindus, A Siemens Healthineers Company and a leading developer of precision vascular robotics, announced today the opening of its new headquarters at 275 Grove Street in Newton, Mass. Siemens Healthineers relocated the Corindus headquarters from its previous location in Waltham to accommodate […]
